Package 10019-080-01

Brand: eribulin mesylate

Generic: eribulin mesylate
NDC Package

Package Facts

Identity

Package NDC 10019-080-01
Digits Only 1001908001
Product NDC 10019-080
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01) / 2 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2024-12-01
Brand eribulin mesylate
Generic eribulin mesylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "d075592c-a613-41ff-975a-e0855110fb75", "openfda": {"upc": ["0310019080017"], "unii": ["AV9U0660CW"], "rxcui": ["1045456"], "spl_set_id": ["62690292-b1de-46f1-b6e8-012a725f8c63"], "manufacturer_name": ["Baxter Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (10019-080-01)  / 2 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "10019-080-01", "marketing_start_date": "20241201"}], "brand_name": "Eribulin Mesylate", "product_id": "10019-080_d075592c-a613-41ff-975a-e0855110fb75", "dosage_form": "INJECTION", "pharm_class": ["Microtubule Inhibition [PE]", "Microtubule Inhibitor [EPC]"], "product_ndc": "10019-080", "generic_name": "Eribulin Mesylate", "labeler_name": "Baxter Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eribulin Mesylate", "active_ingredients": [{"name": "ERIBULIN MESYLATE", "strength": ".5 mg/mL"}], "application_number": "ANDA217250", "marketing_category": "ANDA", "marketing_start_date": "20241001", "listing_expiration_date": "20271231"}